Nevro (NVRO) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

NVRO Stock Forecast


Nevro stock forecast is as follows: an average price target of $32.72 (represents a 511.59% upside from NVRO’s last price of $5.35) and a rating consensus of 'Hold', based on 18 wall street analysts offering a 1-year stock forecast.

NVRO Price Target


The average price target for Nevro (NVRO) is $32.72 based on 1-year price targets from 18 Wall Street analysts in the past 3 months, with a price target range of $125.00 to $5.00. This represents a potential 511.59% upside from NVRO's last price of $5.35.

NVRO Analyst Ratings


Hold

According to 18 Wall Street analysts, Nevro's rating consensus is 'Hold'. The analyst rating breakdown for NVRO stock is 0 'Strong Buy' (0.00%), 7 'Buy' (38.89%), 9 'Hold' (50.00%), 2 'Sell' (11.11%), and 0 'Strong Sell' (0.00%).

Nevro Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 15, 2024David RescottRobert W. Baird$5.00$4.921.63%-6.54%
Aug 08, 2024Joanna WuenschCitigroup$6.89$5.6721.52%28.79%
Aug 08, 2024Richard NewitterTruist Financial$5.50$5.088.27%2.80%
Aug 07, 2024David RescottRobert W. Baird$8.00$5.0060.00%49.53%
Aug 07, 2024Matthew TaylorJefferies$7.00$4.8344.93%30.84%
Aug 07, 2024Adam MaederPiper Sandler$7.00$8.69-19.45%30.84%
Aug 07, 2024Nathan TreybeckWells Fargo$5.50$8.69-36.71%2.80%
Apr 11, 2024Anthony PetroneMizuho Securities$16.00$13.2820.48%199.07%
Apr 08, 2024Nathan TreybeckWells Fargo$14.00$13.295.34%161.68%
Jun 06, 2023Suraj KaliaOppenheimer$40.00$23.7168.72%647.66%
Row per page
Go to

The latest Nevro stock forecast, released on Oct 15, 2024 by David Rescott from Robert W. Baird, set a price target of $5.00, which represents a 1.63% increase from the stock price at the time of the forecast ($4.92), and a -6.54% decrease from NVRO last price ($5.35).

Nevro Price Target by Period


1M3M12M
# Anlaysts179
Avg Price Target$5.00$6.41$8.32
Last Closing Price$5.35$5.35$5.35
Upside/Downside-6.54%19.81%55.51%

In the current month, the average price target of Nevro stock is $5.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a -6.54% decrease as opposed to Nevro's last price of $5.35. This month's average price target is down -22.00% compared to last quarter, and down -39.90% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Aug 08, 2024CitigroupSellNeutralUpgrade
Aug 08, 2024Wolfe Research-Peer PerformUpgrade
Aug 07, 2024JefferiesUnderperformUnderperformHold
Aug 07, 2024Piper SandlerUnderweightUnderweightHold
Aug 07, 2024Wells FargoEqual-WeightUnderweightDowngrade
Aug 07, 2024JMP SecuritiesPerformMarket PerformDowngrade
Aug 07, 2024JMP Securities-PerformDowngrade
Jul 10, 2024CitigroupSellSellHold
May 22, 2024CitigroupNeutralSellDowngrade
Apr 03, 2024CitigroupNeutralNeutralHold
Row per page
Go to

Nevro's last stock rating was published by Citigroup on Aug 08, 2024. The company Upgrade its NVRO rating from "Sell" to "Neutral".

Nevro Financial Forecast


Nevro Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue-------------$103.86M$108.81M$96.33M$113.84M$100.47M$104.21M$87.84M$102.76M$93.20M$102.33M$88.61M$109.73M$108.46M$56.39M$87.47M$114.37M$100.16M
Avg Forecast$137.69M$119.66M$123.90M$109.49M$109.82M$97.28M$104.51M$99.02M$103.31M$93.09M$107.11M$97.90M$112.26M$95.87M$108.19M$95.08M$113.42M$99.22M$104.34M$86.19M$100.26M$91.59M$102.32M$85.26M$107.92M$104.00M$37.86M$88.06M$111.80M$92.27M
High Forecast$137.69M$119.66M$123.90M$109.49M$109.82M$97.28M$104.51M$99.02M$103.31M$93.97M$107.11M$97.90M$112.33M$104.57M$108.19M$95.08M$113.42M$99.22M$104.34M$86.19M$100.26M$91.59M$102.32M$85.26M$107.92M$104.00M$37.86M$88.06M$111.80M$92.27M
Low Forecast$137.69M$119.66M$123.90M$109.49M$109.82M$97.28M$104.51M$99.02M$103.31M$92.00M$107.11M$97.90M$112.05M$94.58M$108.19M$95.08M$113.42M$99.22M$104.34M$86.19M$100.26M$91.59M$102.32M$85.26M$107.92M$104.00M$37.86M$88.06M$111.80M$92.27M
# Analysts1075585448115241599131313137777945443
Surprise %-------------1.08%1.01%1.01%1.00%1.01%1.00%1.02%1.02%1.02%1.00%1.04%1.02%1.04%1.49%0.99%1.02%1.09%

Nevro's average Quarter revenue forecast for Dec 23 based on 4 analysts is $112.26M, with a low forecast of $112.05M, and a high forecast of $112.33M. NVRO's average Quarter revenue forecast represents a 8.09% increase compared to the company's last Quarter revenue of $103.86M (Sep 23).

Nevro EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts1075585448115241599131313137777945443
EBITDA-------------$-25.56M$-25.64M$-36.32M$-19.36M$-18.75M$-20.55M$-30.04M$-24.00M$-44.13M$-13.59M$-20.68M$1.69M$-1.39M$-32.87M$-19.63M$-8.41M$-12.76M
Avg Forecast$-36.14M$-31.40M$-32.52M$-28.73M$-28.82M$-25.53M$-27.43M$-25.99M$-27.11M$-24.43M$-28.11M$-40.31M$-29.46M$-25.16M$-28.39M$-36.65M$-26.40M$-26.04M$-27.38M$-33.31M$-26.31M$-24.04M$-26.85M$-20.44M$-28.32M$-27.29M$-9.93M$-23.80M$-29.34M$-24.22M
High Forecast$-36.14M$-31.40M$-32.52M$-28.73M$-28.82M$-25.53M$-27.43M$-25.99M$-27.11M$-24.14M$-28.11M$-32.25M$-29.41M$-24.82M$-28.39M$-29.32M$-21.12M$-26.04M$-27.38M$-26.65M$-26.31M$-24.04M$-26.85M$-16.35M$-28.32M$-27.29M$-9.93M$-19.04M$-29.34M$-24.22M
Low Forecast$-36.14M$-31.40M$-32.52M$-28.73M$-28.82M$-25.53M$-27.43M$-25.99M$-27.11M$-24.66M$-28.11M$-48.37M$-29.48M$-27.44M$-28.39M$-43.98M$-31.68M$-26.04M$-27.38M$-39.98M$-26.31M$-24.04M$-26.85M$-24.53M$-28.32M$-27.29M$-9.93M$-28.56M$-29.34M$-24.22M
Surprise %-------------1.02%0.90%0.99%0.73%0.72%0.75%0.90%0.91%1.84%0.51%1.01%-0.06%0.05%3.31%0.83%0.29%0.53%

7 analysts predict NVRO's average Quarter EBITDA for Mar 21 to be $-20.44M, with a high of $-16.35M and a low of $-24.53M. This is -1311.54% lower than Nevro's previous annual EBITDA (Dec 20) of $1.69M.

Nevro Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts1075585448115241599131313137777945443
Net Income-------------$-23.48M$-24.72M$-35.03M$-19.19M$81.51M$-24.99M$-34.33M$-30.13M$-50.08M$-21.59M$-29.56M$-7.13M$-9.98M$-41.06M$-24.89M$-13.74M$-17.85M
Avg Forecast$-9.97M$-14.41M$-12.19M$-20.32M$-20.59M$-26.23M$-21.30M$-29.84M$-25.01M$-30.09M$-25.76M$-46.06M$-18.07M$-28.40M$-25.48M$-41.88M$-33.15M$-8.29M$-29.85M$-38.07M$-31.65M$-32.21M$-27.08M$-29.21M$-12.33M$-21.70M$-60.08M$-30.17M$-23.38M$-31.41M
High Forecast$-9.97M$-14.41M$-12.19M$-20.32M$-20.59M$-26.23M$-21.30M$-29.84M$-25.01M$-24.58M$-25.76M$-36.85M$-15.18M$-16.23M$-25.48M$-33.50M$-26.52M$-8.29M$-29.85M$-30.46M$-31.65M$-32.21M$-27.08M$-23.37M$-12.33M$-21.70M$-60.08M$-24.13M$-23.38M$-31.41M
Low Forecast$-9.97M$-14.41M$-12.19M$-20.32M$-20.59M$-26.23M$-21.30M$-29.84M$-25.01M$-35.96M$-25.76M$-55.28M$-20.96M$-33.56M$-25.48M$-50.25M$-39.78M$-8.29M$-29.85M$-45.68M$-31.65M$-32.21M$-27.08M$-35.05M$-12.33M$-21.70M$-60.08M$-36.20M$-23.38M$-31.41M
Surprise %-------------0.83%0.97%0.84%0.58%-9.84%0.84%0.90%0.95%1.55%0.80%1.01%0.58%0.46%0.68%0.83%0.59%0.57%

Nevro's average Quarter net income forecast for Dec 22 is $-33.15M, with a range of $-39.78M to $-26.52M. NVRO's average Quarter net income forecast represents a -140.67% decrease compared to the company's last Quarter net income of $81.51M (Sep 22).

Nevro SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts1075585448115241599131313137777945443
SG&A-------------$81.15M$86.76M$86.19M$80.65M$78.19M$83.97M$79.33M$82.64M$79.52M$73.88M$73.27M$67.07M$68.51M$60.17M$71.40M$76.01M$72.91M
Avg Forecast$106.69M$92.72M$96.01M$84.84M$85.10M$75.38M$80.98M$76.73M$80.05M$72.13M$83.00M$75.86M$86.99M$74.29M$83.83M$73.67M$90.90M$76.88M$80.85M$66.78M$77.69M$70.97M$79.29M$72.40M$83.63M$80.59M$29.33M$86.55M$86.63M$71.50M
High Forecast$106.69M$92.72M$96.01M$84.84M$85.10M$75.38M$80.98M$76.73M$80.05M$72.81M$83.00M$75.86M$87.04M$81.03M$83.83M$73.67M$109.08M$76.88M$80.85M$66.78M$77.69M$70.97M$79.29M$86.88M$83.63M$80.59M$29.33M$103.86M$86.63M$71.50M
Low Forecast$106.69M$92.72M$96.01M$84.84M$85.10M$75.38M$80.98M$76.73M$80.05M$71.29M$83.00M$75.86M$86.83M$73.28M$83.83M$73.67M$72.72M$76.88M$80.85M$66.78M$77.69M$70.97M$79.29M$57.92M$83.63M$80.59M$29.33M$69.24M$86.63M$71.50M
Surprise %-------------1.09%1.03%1.17%0.89%1.02%1.04%1.19%1.06%1.12%0.93%1.01%0.80%0.85%2.05%0.83%0.88%1.02%

Nevro's average Quarter SG&A projection for Dec 23 is $86.99M, based on 4 Wall Street analysts, with a range of $86.83M to $87.04M. The forecast indicates a 7.20% rise compared to NVRO last annual SG&A of $81.15M (Sep 23).

Nevro EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts1075585448115241599131313137777945443
EPS-------------$-0.65$-0.69$-0.98$-0.54$2.30$-0.71$-0.98$-0.86$-1.44$-0.62$-0.85$-0.21$-0.29$-1.21$-0.78$-0.44$-0.58
Avg Forecast$-0.27$-0.39$-0.33$-0.55$-0.56$-0.71$-0.58$-0.81$-0.68$-0.81$-0.70$-1.05$-0.49$-0.77$-0.69$-1.05$-0.49$-0.22$-0.81$-1.10$-0.86$-0.87$-0.73$-0.85$-0.33$-0.59$-1.63$-0.99$-0.63$-0.85
High Forecast$-0.27$-0.39$-0.33$-0.55$-0.56$-0.71$-0.58$-0.81$-0.68$-0.67$-0.70$-1.05$-0.41$-0.44$-0.69$-1.05$-0.49$-0.22$-0.81$-1.10$-0.86$-0.87$-0.73$-0.85$-0.33$-0.59$-1.63$-0.99$-0.63$-0.85
Low Forecast$-0.27$-0.39$-0.33$-0.55$-0.56$-0.71$-0.58$-0.81$-0.68$-0.97$-0.70$-1.05$-0.57$-0.91$-0.69$-1.05$-0.49$-0.22$-0.81$-1.10$-0.86$-0.87$-0.73$-0.85$-0.33$-0.59$-1.63$-0.99$-0.63$-0.85
Surprise %-------------0.85%1.00%0.93%1.11%-10.25%0.88%0.89%1.00%1.65%0.85%1.00%0.63%0.49%0.74%0.79%0.70%0.68%

According to 13 Wall Street analysts, Nevro's projected average Quarter EPS for Dec 22 is $-0.49, with a low estimate of $-0.49 and a high estimate of $-0.49. This represents a -121.20% decrease compared to NVRO previous annual EPS of $2.30 (Sep 22).

Nevro Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
NVRONevro$5.35$32.72511.59%Hold
SGHTSight Sciences$4.66$10.25119.96%Hold
NPCENeuroPace$6.37$12.88102.20%Buy
FNAParagon 28$6.06$11.5089.77%Buy
OFIXOrthofix Medical$17.33$31.0078.88%-
LUNGPulmonx$7.12$11.9367.56%Buy
LIVNLivaNova$49.01$70.5043.85%Buy
KIDSOrthoPediatrics$28.74$39.6037.79%Buy
RXSTRxSight$51.25$70.1136.80%Buy
CNMDCONMED$70.47$96.0036.23%Buy
IRMDIRadimed$49.36$60.0021.56%Buy
ITGRInteger$126.53$138.009.07%Buy
CVRXCVRx$15.05$16.338.50%Buy
SRDXSurmodics$37.57$39.505.14%Buy
GKOSGlaukos$131.38$119.33-9.17%Buy

NVRO Forecast FAQ


No, according to 18 Wall Street analysts, Nevro (NVRO) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 7 'Buy' recommendations, accounting for 38.89% of NVRO's total ratings.

Nevro (NVRO) average price target is $32.72 with a range of $5 to $125, implying a 511.59% from its last price of $5.35. The data is based on 18 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

According to Wall Street analysts' prediction for NVRO stock, the company can go up by 511.59% (from the last price of $5.35 to the average price target of $32.72), up by 2236.45% based on the highest stock price target, and down by -6.54% based on the lowest stock price target.

NVRO's average twelve months analyst stock price target of $32.72 supports the claim that Nevro can reach $8 in the near future.

1 Wall Street analyst forecast a $5 price target for Nevro (NVRO) this month, down -6.54% from its last price of $5.35. Compared to the last 3 and 12 months, the average price target increased by 19.81% and increased by 55.51%, respectively.

Nevro's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $410.64M (high $410.64M, low $410.64M), average EBITDA is $-108M (high $-108M, low $-108M), average net income is $-97.955M (high $-97.955M, low $-97.955M), average SG&A $318.19M (high $318.19M, low $318.19M), and average EPS is $-2.652 (high $-2.652, low $-2.652). NVRO's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $490.74M (high $490.74M, low $490.74M), average EBITDA is $-129M (high $-129M, low $-129M), average net income is $-56.883M (high $-56.883M, low $-56.883M), average SG&A $380.26M (high $380.26M, low $380.26M), and average EPS is $-1.54 (high $-1.54, low $-1.54).

Based on Nevro's last annual report (Dec 2022), the company's revenue was $406.36M, beating the average analysts forecast of $403.17M by 0.79%. Apple's EBITDA was $-204M, beating the average prediction of $-113M by 80.17%. The company's net income was $3M, missing the average estimation of $-109M by -102.74%. Apple's SG&A was $322.14M, beating the average forecast of $315.42M by 2.13%. Lastly, the company's EPS was $0.08, missing the average prediction of $-2.621 by -103.05%. In terms of the last quarterly report (Sep 2023), Nevro's revenue was $103.86M, beating the average analysts' forecast of $95.87M by 8.34%. The company's EBITDA was $-25.559M, beating the average prediction of $-25.16M by 1.59%. Nevro's net income was $-23.479M, missing the average estimation of $-28.4M by -17.33%. The company's SG&A was $81.15M, beating the average forecast of $74.29M by 9.24%. Lastly, the company's EPS was $-0.65, missing the average prediction of $-0.769 by -15.46%